Lucila B. Nwatu

FDA investigator

Appears on 18 documents from 2015 to 2026, mostly at sites in California. Most often cites control of microbiological contamination (21 CFR 211.113).

18
Documents on file
5.5
Observations per 483
2015
First seen
2026
Most recent

What they cite most

From 97 observations

Activity by year

2015: 5, 2016: 3, 2017: 2, 2018: 2, 2024: 2, 2025: 3, 2026: 1

Where

California 9 · Colorado 3 · Nevada 3 · Germany 1 · New Jersey 1 · South Korea 1

Is Lucila B. Nwatu coming to your site?

Our team writes custom reports before an inspection: what this investigator cites most, how they write it up, and how your site's history compares, in one brief you can circulate.

Ask about any investigator in Claude or ChatGPT with the AI connector.

Inspection history

18 documents, newest first
FirmOpen
483 Imprimis NJOF, LLCAug 18, 2026 · Ledgewoo d, New Jersey
483 Nubratori, Inc.Dec 11, 2025 · To rrance, California
483 BSO LLCJul 16, 2025 · Lakewood, Colorado
483 BSO , LLCJun 27, 2025 · Go lden, Colorado
483 Nubratori, Inc.Jul 26, 2024 · Torrance, California
483 BSO LLCJun 25, 2024 · Lakewood, Colorado
483 Samsung Biologics Co., Ltd.Jun 26, 2018 · Incheon, South Korea

About this profile

What does Lucila B. Nwatu inspect?

Lucila B. Nwatu appears on 18 documents on file covering 15 sites, mostly in California.

What do they cite most often?

21 CFR 211.113 (control of microbiological contamination), followed by 21 CFR 211.67 and 21 CFR 211.160.

Can I read the observations?

Each document page previews the opening words of every observation. The full documents are available to buy, one at a time or together.

How current is this profile?

The most recent document on file for Lucila B. Nwatu is dated Aug 18, 2026.